Makary's exit creates new uncertainty at FDA

Axios · May 13, 2026 · 600 words · By Adriel Bettelheim

Trump Administration Personnel Changes Political Influence on Regulatory Agencies FDA Leadership Instability

headphones Listen to the eFinder podcast briefing

Generate a natural audio summary of this story

Daily briefing

What to know about Trump Administration Personnel Changes

The article reports on the departure of Marty Makary from the FDA and the subsequent appointment of Kyle Diamantas as the interim leader. It discusses the internal instability at the agency, the political pressures surrounding the selection of a permanent successor, and reactions from political and industry figures.

Propaganda risk 20%

Claims checked 13

Techniques found 1

Topics 3

Coverage spectrum

Coverage gap: Low Right coverage

Left20%

Center80%

Right0%

5 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Marty Makary's departure from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy.

Why it matters

But it won't solve the organizational upheaval and political jockeying that marked much of his 13-month tenure.

Common ground

Why it matters: There's lots of uncertainty around how the Senate will find the bandwidth to confirm another FDA commissioner while it considers President Trump's nominees for Centers for Disease Control and Prevention director and surgeon general.

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

Follow-up questions

What new context would change how readers understand this Trump Administration Personnel Changes story?
What evidence would most clearly confirm or weaken the claim that Marty Makary's departure from the Food and Drug Administration?
How does this story connect Trump Administration Personnel Changes with Political Influence on Regulatory Agencies over the next few days?

open_in_new Read the original article: https://axios.com/2026/05/13/makary-fda-departure-whats-next

analyticsAnalysis

20%

Propaganda Score

confidence: 95%

Minor concerns. Some persuasive language detected, but largely factual.

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning

Loaded Language 80% confidence

Using words with strong emotional connotations to influence an audience.

Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.

Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 13 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 6

schedule Pending 3

help Insufficient Evidence 2

info Single Source 1

verified Verified By Reference 1

check_circle

Claim 1: “Marty Makary's departure from the Food and Drug Administration”

CORROBORATED

Multiple independent sources, including The Guardian and other news reports, confirm that Marty Makary has departed/resigned from the FDA.

travel_explore

web search NEUTRAL — Martin Adel Makary is a British-American surgeon, professor, author, and medical commentator who has been the 27th commissioner of food and drugs since 2025.
https://en.wikipedia.org/wiki/Marty_Makary

travel_explore

web search NEUTRAL — Marty Makary departs FDA after clashes with Trump over fruit-flavored vapes. 16 hours ago.Head of the Food and Drug Administration resigns. 9 hours ago. Save for later.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…

travel_explore

web search NEUTRAL — Getty Images Commissioner of Food and Drug Administration Marty Makary delivers remarks alongside, U.S. President Donald Trump, Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz…
https://www.bbc.com/news/articles/ce8pg3kr3pxo

info

Claim 2: “The FDA itself is also facing other key internal vacancies, including for directors of the centers overseeing drugs and biologics.”

SINGLE SOURCE

While the evidence confirms Makary's resignation and the general role of the FDA, none of the provided search results specifically confirm that there are currently vacancies for directors of the centers overseeing drugs and biologics.

travel_explore

web search NEUTRAL — The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services (HHS).
https://en.wikipedia.org/wiki/Food_and_Drug_Administration

travel_explore

web search NEUTRAL — Apr 29, 2026 · The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by en…
https://www.fda.gov/

travel_explore

web search NEUTRAL — 20 hours ago · Dr. Marty Makary resigned as commissioner of the Food and Drug Administration on Tuesday in the fourth high-profile departure of a member of the Trump administration this year. Subscrib…
https://www.nbcnews.com/health/health-news/dr-marty-makary-f…

check_circle

Claim 3: “On Tuesday, Trump confirmed Makary was out”

CORROBORATED

UPI and other reports explicitly state that President Donald Trump confirmed Makary's departure on a Tuesday.

travel_explore

web search NEUTRAL — Marty Makary, the FDA commissioner, also clashed with lawmakers about drug regulation decisions and a review of mifepristone, an abortion medication. Photograph: Mark Schiefelbein/AP.
https://www.theguardian.com/us-news/2026/may/12/marty-makary…

travel_explore

web search NEUTRAL — Former FDA Commissioner Marty Makary. Makary at a December event at the Department of Health and Human Services.Marty Makary's departure from the Food and Drug Administration may remove one of the Tru…
https://www.axios.com/2026/05/13/makary-fda-departure-whats-…

travel_explore

check_circle

Claim 4: “He later wrote on Truth Social that the Johns Hopkins physician and researcher 'was a hard worker'”

CORROBORATED

Multiple sources confirm Marty Makary is a Johns Hopkins surgeon/physician, and Forbes mentions Trump's posts regarding the resignation.

travel_explore

web search NEUTRAL — President-elect Trump has tapped Johns Hopkins surgeon Martin "Marty" Makary, who has made a name for himself by challenging status quo ideas in the medical establishment, to serve as the next ...
https://www.statnews.com/2024/11/22/trump-fda-nominee-marty-…

travel_explore

web search NEUTRAL — Topline FDA Commissioner Dr. Marty Makary resigned from the agency Tuesday in the wake of reports that President Donald Trump had been considering firing him for months as he faced Republican ...
https://www.forbes.com/sites/saradorn/2026/05/12/fda-commiss…

travel_explore

web search NEUTRAL — President-elect Donald Trump has nominated Marty Makary, MD, a pancreatic surgeon at Johns Hopkins University in Baltimore, as commissioner of the FDA, NBC News reported Nov. 22. 1. Dr. Makary is chie…
https://www.beckersasc.com/leadership/trump-picks-johns-hopk…

check_circle

Claim 5: “David Mansdoerfer, a senior HHS official in the first Trump administration, wrote on X that Diamantas had the regulatory and legal chops to lead a transition”

CORROBORATED

Two separate search results explicitly quote David Mansdoerfer's post on X regarding Diamantas's regulatory and legal chops and the 'MAHA' pick.

travel_explore

web search NEUTRAL — Between the lines: David Mansdoerfer, a senior HHS official in the first Trump administration, wrote on X that Diamantas had the regulatory and legal chops to lead a transition and also was "a good pi…
https://www.axios.com/2026/05/13/makary-fda-departure-whats-…

travel_explore

web search NEUTRAL — David Mansdoerfer, a senior HHS official in Trump’s first administration, praised Diamantas on X (formerly Twitter), stating he had the regulatory and legal expertise to manage a transition and called…
https://xeber.world/en/article/makarys-exit-creates-new-unce…

travel_explore

web search NEUTRAL — David Mansdoerfer Healthcare Policy Expert Public Policy Strategist Champion for Medical Freedom 15+ years of experience About David David Mansdoerfer is a nationally respected voice in healthcare pol…
https://davidmansdoerfer.com/

check_circle

Claim 6: “his 13-month tenure”

CORROBORATED

Three separate web search results explicitly state that Marty Makary's tenure at the FDA lasted 13 months.

travel_explore

web search NEUTRAL — After a tumultuous 13 months at the helm of the U.S. Food and Drug Administration, Marty Makary has resigned.
https://www.npr.org/2026/05/13/nx-s1-5819861/fda-commissione…

travel_explore

web search NEUTRAL — FDA Commissioner Marty Makary steps down after a turbulent 13-month tenure marked by drug approval controversies, White House tensions, and leadership turnover. Learn about the key issues and what's n…
https://xeber.world/en/article/fda-commissioner-marty-makary…

travel_explore

web search NEUTRAL — May 12 (UPI) -- Food and Drug Administration Commissioner Marty Makary has left the administration after 13 months at that post, President Donald Trump confirmed Tuesday.
https://www.yahoo.com/news/articles/fda-commissioner-martin-…

check_circle

Claim 7: “The task of steering the agency for the moment will fall to Kyle Diamantas, a Florida lawyer and reported friend of Donald Trump Jr. who was heading the FDA's food center.”

CORROBORATED

Multiple sources identify Kyle Diamantas as a Florida lawyer and head of the FDA's food center who has been tapped to lead the agency/food center in the interim.

travel_explore

web search NEUTRAL — Diamantas currently leads FDA food division. Diamantas currently serves as the FDA’s Deputy Commissioner for Food, overseeing the agency’s Human Foods Program.
https://www.msn.com/en-in/news/world/who-is-kyle-diamantas-f…

travel_explore

web search NEUTRAL — In the interim, Kyle Diamantas, a Florida lawyer and reported friend of Donald Trump Jr., has been tapped to lead the FDA’s food center. Diamantas previously headed the agency’s food division.
https://xeber.world/en/article/fda-commissioner-marty-makary…

travel_explore

web search NEUTRAL — Head of the Food and Drug Administration resigns.FDA’s leadership shakeup elevates food program insider amid questions over science, staffing and MAHA influence.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…

verified

Claim 8: “former FDA commissioner Stephen Hahn and Brett Giroir, who was briefly acting commissioner”

VERIFIED BY REFERENCE

Wikipedia confirms Stephen Hahn was the FDA commissioner (2019-2021), and a legal review source confirms Brett Giroir served as acting interim commissioner.

travel_explore

web search NEUTRAL — Stephen Michael Hahn is an American physician who served as the commissioner of food and drugs from 2019 to 2021. Before becoming commissioner, he was an oncologist serving as chief medical executive …
https://en.wikipedia.org/wiki/Stephen_Hahn

travel_explore

web search NEUTRAL — With the departure of Commissioner Stephen Hahn, Dr. Woodcock served as Acting Commissioner of Food and Drugs, where she led the agency’s response to the COVID-19 public health emergency and introduce…
https://www.fda.gov/about-fda/fda-leadership-1907-today/acti…

travel_explore

web search NEUTRAL — 2019 was a robust year for the US Food and Drug Administration’s (FDA’s) regulatory agenda.Most notably, Commissioner Scott Gottlieb resigned on April 5. Norman Sharpless and Brett Giroir served as ac…
https://www.mcdermottlaw.com/insights/fda-2019-year-in-revie…

help

Claim 9: “Raymond James analyst Chris Meekins wrote in a note”

INSUFFICIENT EVIDENCE

No evidence was found in the provided search results regarding Chris Meekins or Raymond James.

schedule

Claim 10: “John Crowley, CEO of the biotech trade group BIO”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 11: “Sen. Dick Durbin (D-Ill.)”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

help

Claim 12: “former top vaccine regulator Vinay Prasad”

INSUFFICIENT EVIDENCE

No evidence was found in the provided search results to confirm Vinay Prasad served as a top vaccine regulator at the FDA.

schedule

Claim 13: “Senate health committee, whose chairman, Bill Cassidy (R-La)”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.